Prediction of fetal anaemia.

Curr Opin Obstet Gynecol

Academic Department of Obstetrics and Gynaecology, The Homerton Hospital, London, UK.

Published: April 2002

The perinatal outcome of the anaemic fetus has dramatically improved over the last 20 years, as a result of early recognition of the problem and treatment by intrauterine transfusion. Traditionally assessment of the anaemic fetus relied on obstetric history and maternal antibody titre, which proved to be inadequate tests to accurately predict fetal condition. More recently, invasive testing with techniques such as amniocentesis and cordocentesis have allowed a more accurate evaluation of the degree of anaemia, while at the same time enabling transfusion to take place. Such techniques are not without danger, with perinatal loss and fetomaternal haemorrhage being significant risks. The clinical community has therefore sought to find accurate, non-invasive methods for assessing the degree of fetal anaemia, thereby reducing the number of unnecessary invasive procedures, while at the same time providing more precise data on the quantity and timing of the transfusion. Recent publications focusing on the diagnosis and management (including plasmapheresis, immunoglobulins and intrauterine transfusion) of fetal anaemia will be discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00001703-200204000-00012DOI Listing

Publication Analysis

Top Keywords

fetal anaemia
12
anaemic fetus
8
intrauterine transfusion
8
prediction fetal
4
anaemia
4
anaemia perinatal
4
perinatal outcome
4
outcome anaemic
4
fetus dramatically
4
dramatically improved
4

Similar Publications

Objective: Fetomaternal transfusion (FMT) is associated with increased perinatal mortality and morbidity, but data on postnatal outcomes are scarce. Our aim was to determine the incidence of adverse short-termand long-term sequelae of severe FMT.

Design: Retrospective cohort study.

View Article and Find Full Text PDF

Maternal Sepsis and associated factors: A multi-central study from two tertiary care hospitals of South Punjab, Pakistan.

Pak J Med Sci

January 2025

Sadia Nazir, FCPS Assistant Professor, Obstetrics and Gynaecology Department, DG Khan Medical College, DG Khan, Pakistan.

Objective: To determine the risk factors and outcomes of maternal sepsis.

Methods: This case-control study was performed at the departments of Obstetrics & Gynecology, Nishtar Hospital, Multan, and Ghazi Khan Hospital, Dera Ghazi Khan, Pakistan, from June 2023 to May 2024. Cases were comprised of females aged 18-45 years diagnosed with maternal sepsis, and admitted during the study period.

View Article and Find Full Text PDF

Non-invasive prenatal testing (NIPT) has been widely adopted for the screening of chromosomal abnormalities; however, its adoption for monogenic disorders, such as β-thalassaemia, has proven challenging. Haemoglobinopathies are the most common monogenic disorders globally, with β-thalassaemia being particularly prevalent in Cyprus. This study introduces a non-invasive prenatal haplotyping (NIPH) assay for β-thalassaemia, utilizing cell-free DNA (cfDNA) from maternal plasma.

View Article and Find Full Text PDF

Fetal Hemoglobin as a Predictive Biomarker for Retinopathy of Prematurity: A Prospective Multicenter Cohort Study in Portugal.

Biomedicines

January 2025

Ecogenetics and Human Health Unit, Environmental Health Institute (ISAMB), Associate Laboratory TERRA, Faculty of Medicine, University of Lisbon, Av. Professor Egas Moniz, 1649-028 Lisbon, Portugal.

Retinopathy of prematurity (ROP) is a leading cause of vision impairment in preterm infants, with its pathogenesis linked to oxygen exposure. Red blood cell (RBC) transfusions, commonly performed in neonatal intensive care units (NICUs), reduce fetal hemoglobin (HbF) fraction, altering oxygen dynamics and potentially contributing to ROP. We aimed to investigate the relationship between RBC transfusions, HbF percentage, and ROP, evaluating HbF as a potential predictive biomarker.

View Article and Find Full Text PDF

Fanconi anemia (FA) is a rare genetic disorder that affects multiple systems in the body and is the most prevalent congenital syndrome, leading to bone marrow failure. Twenty-two genes have been identified as contributors to the disease. Significant advancements have been made in the past 2 decades in understanding the genetic and pathophysiological processes involved.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!